2016
Effectiveness of Residential Acaricides to Prevent Lyme and Other Tick-borne Diseases in Humans
Hinckley A, Meek J, Ray J, Niesobecki S, Connally N, Feldman K, Jones E, Backenson P, White J, Lukacik G, Kay A, Miranda W, Mead P. Effectiveness of Residential Acaricides to Prevent Lyme and Other Tick-borne Diseases in Humans. The Journal Of Infectious Diseases 2016, 214: 182-188. PMID: 26740276, PMCID: PMC10874626, DOI: 10.1093/infdis/jiv775.Peer-Reviewed Original ResearchConceptsTick-borne diseasesHuman-tick encountersMajor public health concernPlacebo-controlled trialMedical record reviewHuman tick-borne diseasesReports of illnessPublic health concernPublic health authoritiesTick-borne diseaseRecord reviewTick biteTick exposureTreatment groupsHealth authoritiesDiseaseHealth concernQuesting ticksHuman outcomesTicksUse of acaricidesIllnessIncidenceTrialsWeeks
2012
Guillain-Barré Syndrome During the 2009–2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans
Wise M, Viray M, Sejvar J, Lewis P, Baughman A, Connor W, Danila R, Giambrone G, Hale C, Hogan B, Meek J, Murphree R, Oh J, Reingold A, Tellman N, Conner S, Singleton J, Lu P, DeStefano F, Fridkin S, Vellozzi C, Morgan O. Guillain-Barré Syndrome During the 2009–2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans. American Journal Of Epidemiology 2012, 175: 1110-1119. PMID: 22582209, PMCID: PMC3888111, DOI: 10.1093/aje/kws196.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedChildChild, PreschoolFemaleGuillain-Barre SyndromeHealth PromotionHumansIncidenceInfantInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInfluenza, HumanMaleMiddle AgedPopulation SurveillanceProduct Surveillance, PostmarketingRisk AssessmentTime FactorsUnited StatesYoung AdultConceptsGuillain-Barré syndromePopulation-based surveillanceGBS casesPH1N1 vaccineInfluenza A (H1N1) 2009 monovalent vaccineRate of GBSEmerging Infections Program sitesSex-adjusted rate ratiosH1N1 influenza vaccineMedical record reviewVaccine coverage dataInfluenza vaccination campaignGBS incidencePH1N1 vaccinationInfluenza vaccineMonovalent vaccineRecord reviewIncident casesVaccine dosesExcess riskPatient interviewsGBS riskVaccine campaignVaccine historyVaccination campaignHuman Papillomavirus Vaccination History Among Women With Precancerous Cervical Lesions
Mehta NR, Julian PJ, Meek JI, Sosa LE, Bilinski A, Hariri S, Markowitz LE, Hadler JL, Niccolai LM. Human Papillomavirus Vaccination History Among Women With Precancerous Cervical Lesions. Obstetrics And Gynecology 2012, 119: 575-581. PMID: 22353956, DOI: 10.1097/aog.0b013e3182460d9f.Peer-Reviewed Original ResearchConceptsHuman papillomavirus vaccination historyAbnormal cytology resultsPrecancerous cervical lesionsCervical lesionsHPV vaccineVaccination historyCytology resultsHigh-grade cervical lesionsPrivate insuranceMedical record reviewTiming of vaccinationHistory of vaccinationPublic health surveillanceAfrican American womenUnvaccinated womenUninsured womenRecord reviewSurveillance registryMore dosesMean ageProvider recommendationVaccination strategiesVaccinationHealth surveillanceLesions